Aktis Oncology, Inc.

Aktis Oncology, Inc.verified

AKTS

Price:

$19.71

Market Cap:

$1.04B

Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment. The company offers a miniprotein radioconjugate platform to discover and develop radiopharmaceutical therapies that deliver the tumor-killing properties of radioisotopes. It offers Nectin-4, a miniprotein radioconjugate for the treatment of locally advanced or metastatic urothelial cancer. Its products include AKY-1189 to deliver a radioisotope to Nectin-4 expressing tumors for the treatment of metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and AKY-2519 to deliver radioisotope to B7-H3 CD...[Read more]

Industry

Biotechnology

IPO Date

2026-01-09

Stock Exchange

NASDAQ

Ticker

AKTS

The PE Ratio as of February 2026 (TTM) for Aktis Oncology, Inc. (AKTS) is -17.14

According to Aktis Oncology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -17.14. This represents a change of -Infinity% compared to the average of 0 of the last 4 quarters.

Aktis Oncology, Inc. (AKTS) Historical PE Ratio (quarterly & annually)

How has AKTS PE Ratio performed in the past?

The mean historical PE Ratio of Aktis Oncology, Inc. over the last ten years is 0. The current -17.14 PE Ratio has changed -Infinity% with respect to the historical average. Over the past ten years (40 quarters), AKTS's PE Ratio was at its highest in in the September 2024 quarter at 0. The PE Ratio was at its lowest in in the September 2024 quarter at 0.

Quarterly (TTM)
Annual

Average

0

Median

0

Minimum

0

Maximum

0

Aktis Oncology, Inc. (AKTS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Aktis Oncology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = 0

Minimum Annual Increase = 0%

Minimum Annual PE Ratio = 0

Quarterly (TTM)
Annual
YearPE RatioChange
202400%
202300%

Aktis Oncology, Inc. (AKTS) Average PE Ratio

How has AKTS PE Ratio performed in the past?

The current PE Ratio of Aktis Oncology, Inc. (AKTS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0

5-year avg

0

10-year avg

0

Aktis Oncology, Inc. (AKTS) PE Ratio vs. Peers

How is AKTS’s PE Ratio compared to its peers?

Aktis Oncology, Inc.’s PE Ratio is

CompanyPE RatioMarket cap

Build a custom stock screener for Aktis Oncology, Inc. (AKTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aktis Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aktis Oncology, Inc. (AKTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aktis Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Aktis Oncology, Inc.'s PE Ratio?

How is the PE Ratio calculated for Aktis Oncology, Inc. (AKTS)?

What is the highest PE Ratio for Aktis Oncology, Inc. (AKTS)?

What is the 3-year average PE Ratio for Aktis Oncology, Inc. (AKTS)?

What is the 5-year average PE Ratio for Aktis Oncology, Inc. (AKTS)?

How does the current PE Ratio for Aktis Oncology, Inc. (AKTS) compare to its historical average?